Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products

Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products

CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing agreement with Finceramica Faenza S.p.A., an innovative Italian biomaterials company. The three-year extension strengthens the longstanding partnership, granting Kelyniam expanded access to Finceramica's advanced product portfolio, including SI…

Kelyniam (OTC: KLYG) renews 3-year Finceramica license, gains SINTlife access

Kelyniam renews Finceramica license for three years, gaining SINTlife access. FDA clearance is expected within 2 years, targeting markets about 10x larger.